Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)

NCT05963464 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT05963464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05963464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2023
Completion date
December 31, 2024
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, occult breast carcinoma